Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study)-Reference-Cited by-同舟云学术

Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study)

Published:2006-04-04 Issue:6 Volume:20 Page:795-803
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Castagna Antonella,Danise Anna,Menzo Stefano,Galli Laura,Gianotti Nicola,Carini Elisabetta,Boeri Enzo,Galli Andrea,Cernuschi Massimo,Hasson Hamid,Clementi Massimo,Lazzarin Adriano

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference24 articles.

1. Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment response;Deeks;AIDS,2003

2. Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures: a randomized controlled trial (ANRS 097);Katlama;AIDS,2004

3. Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia;Deeks;N Engl J Med,2001

4. Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus;Lawrence;N Engl J Med,2003

5. No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients;Ghosn;AIDS,2005

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Management Challenges in Naïve and Experienced HIV-1-Infected Individuals Carrying the M184V Mutation;Viruses;2024-08-30

2. Evolution driven by a varying host environment selects for distinct HIV-1 entry phenotypes and other informative variants;Frontiers in Virology;2023-11-16

3. Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysis;Open Forum Infectious Diseases;2023-10-27

4. The impact of the M184V resistance mutation on treatment outcomes in patients with HIV infection: a systematic review and meta-analysis;Aids Reviews;2023-10-20

5. BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022;HIV Medicine;2022-12